The govt is planning to replace home-based, unequal burn care with a uniform, evidence-based protocol to reduce deaths and ...
The FDA has granted 510(k) clearance to a Bay Area medical technology firm for its proprietary delirium monitoring solution, the first and only such device to receive FDA clearance, according to the ...
Detailed price information for Ventripoint Diagnostics Ltd (VPT-X) from The Globe and Mail including charting and trades.
Issued on behalf of VentriPoint Diagnostics Ltd. Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device and ...
CeriBell Inc. CBLL recently announced that the FDA has given 510(k) clearance for its latest delirium monitoring solution, making it the one and only FDA-cleared solution for continuous tracking of ...
Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to address long unmet need in delirium monitoring SUNNYVALE, Calif., Dec. 09, ...
SUNNYVALE, Calif. - Ceribell, Inc. (NASDAQ:CBLL) has received 510(k) clearance from the U.S. Food and Drug Administration for its delirium monitoring solution, according to a company press release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results